Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone versus methylprednisolone intra-articular injection for frozen shoulder
IRCT20180423039388N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of betamethasone, methylprednisolone and lidocaine in adhesive capsulitis (AC) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Pain via Visual Analog Scale at 6 months, Shoulder range of motion at 6 months and 1 more. Started Jan 2024; status: completed.
02
Drugs
betamethasonemethylprednisolonelidocaine
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on IRCT20180423039388N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180423039388N1.